Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Polygala senega
North American prairie plant root used by the Seneca nation to treat rattlesnake bites and as expectorant, adopted into European pharmacopoeia.
Seneca snakeroot (Polygala senega) is a North American prairie plant whose root has been traditionally used by Indigenous peoples as an antidote for rattlesnake bites and as a respiratory expectorant. It contains triterpenoid saponins (senegin, senegenin) and methyl salicylate, which contribute to its expectorant, mucolytic, diaphoretic, and anti-inflammatory actions. Modern evidence is limited (Level C), but it remains in some herbal pharmacopoeias for bronchitis and rheumatic conditions.
The expectorant and mucolytic effects are primarily attributed to saponins (senegin, senegenin) that stimulate gastric vagal reflexes, increasing respiratory tract fluid secretion and reducing mucus viscosity. Methyl salicylate provides mild anti-inflammatory and analgesic activity via COX inhibition, while the diaphoretic action may involve transient thermoregulatory changes. Additionally, saponins may modulate immune responses by enhancing phagocytosis and reducing pro-inflammatory cytokines.
North American prairie plant root used by the Seneca nation to treat rattlesnake bites and as expectorant, adopted into European pharmacopoeia.
Seneca snakeroot (Polygala senega) is a North American prairie plant whose root has been traditionally used by Indigenous peoples as an antidote for rattlesnake bites and as a respiratory expectorant. It contains triterpenoid saponins (senegin, senegenin) and methyl salicylate, which contribute to its expectorant, mucolytic, diaphoretic, and anti-inflammatory actions. Modern evidence is limited (Level C), but it remains in some herbal pharmacopoeias for bronchitis and rheumatic conditions.
The expectorant and mucolytic effects are primarily attributed to saponins (senegin, senegenin) that stimulate gastric vagal reflexes, increasing respiratory tract fluid secretion and reducing mucus viscosity. Methyl salicylate provides mild anti-inflammatory and analgesic activity via COX inhibition, while the diaphoretic action may involve transient thermoregulatory changes. Additionally, saponins may modulate immune responses by enhancing phagocytosis and reducing pro-inflammatory cytokines.